GAMBARAN PENGGUNAAN OBAT PADA PASIEN
COVID-19 DI RUANG ISOLASI COVID “RUMAH SAKIT
UMUM DAERAH KOTA SURAKARTA†PERIODE
MARET 2020 - OKTOBER 2020
Total View This Week0
Total View This Week0
Institusion
Sekolah Tinggi Ilmu Kesehatan Nasional
Author
Ratna, Widyasari
Subject
RN Pharmacy and Pharmaceutical Mathematics
Datestamp
2022-04-14 06:37:59
Abstract :
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS_CoV-2) is the virus that causes Covid-19. The virus originated in Wuhan, China, in December 2019 and has spread throughout the world at this time. This disease can be asymptomatic or without symptoms to symptoms such as fever, sore throat, cough, lung infection, and in severe cases acute respiratory distress syndrome. Currently in Indonesia is still struggling to reduce the spread of Covid-19. This research was conducted using non-experimental descriptive research method with retrospective data collection at RSUD Kota Surakarta. The study was conducted to obtain data regarding the description of therapy in patients being treated in Covid-19 isolation at RSUD Kota Surakarta. From the results of the research conducted, it was obtained data that Covid-19 patients at RSUD Kota Surakarta dominated by those over 45 years old (46-5 years old at 33.33%, 56-65 years old at 16.70%, and > 65 years old by 21.70%). For gender, it is 55% for men and 45% for women. Patients with comorbid hypertension and kidney disorders obtained the highest percentage results, each at 35.00%, followed by diabetes mellitus at 32.00%, with liver disorders at 3.00%, while without comorbidities at 27.00%. Based on the use of drugs, the highest results were shown in the use of antibiotics (88.33%), antacids and anti-ulcers (86.67%), vitamins, minerals and supplements (78.33%), analgesics and antipyretics (66.67%), expectorants. (45.00%), antihypertensive (41.67%), antiviral (30.00%), drugs that affect coagulation (25.00%), antidiabetic (21.67%), antiasma (20.00%), corticosteroids (13.33%), anti-malarial (10.00%), anti-diarrheal (5.00%), and antitussive (3.33%).
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS_CoV-2) is the virus that causes Covid-19. The virus originated in Wuhan, China, in December 2019 and has spread throughout the world at this time. This disease can be asymptomatic or without symptoms to symptoms such as fever, sore throat, cough, lung infection, and in severe cases acute respiratory distress syndrome. Currently in Indonesia is still struggling to reduce the spread of Covid-19. This research was conducted using non-experimental descriptive research method with retrospective data collection at RSUD Kota Surakarta. The study was conducted to obtain data regarding the description of therapy in patients being treated in Covid-19 isolation at RSUD Kota Surakarta. From the results of the research conducted, it was obtained data that Covid-19 patients at RSUD Kota Surakarta dominated by those over 45 years old (46-5 years old at 33.33%, 56-65 years old at 16.70%, and > 65 years old by 21.70%). For gender, it is 55% for men and 45% for women. Patients with comorbid hypertension and kidney disorders obtained the highest percentage results, each at 35.00%, followed by diabetes mellitus at 32.00%, with liver disorders at 3.00%, while without comorbidities at 27.00%. Based on the use of drugs, the highest results were shown in the use of antibiotics (88.33%), antacids and anti-ulcers (86.67%), vitamins, minerals and supplements (78.33%), analgesics and antipyretics (66.67%), expectorants. (45.00%), antihypertensive (41.67%), antiviral (30.00%), drugs that affect coagulation (25.00%), antidiabetic (21.67%), antiasma (20.00%), corticosteroids (13.33%), anti-malarial (10.00%), anti-diarrheal (5.00%), and antitussive (3.33%).
Download
book
BibTex
Latex, Jabref
cloud_download
Original Resource
url resource Institution
